Solstice Biologics' Series A - II Round

Solstice Biologics raised a round of funding on December 30, 2015.

Solstice Biologics is a private company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. The company is developing small, cell-permeable RNAi pro-drugs that can e…

Articles about Solstice Biologics' Series A - II Round: